Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Recursion Pharmaceuticals
Biotech
Recursion, Canaan, Metsera and more—Chutes & Ladders
Recursion plucks J&J chief data science officer. Canaan adds ex-Pfizer R&D leader as venture partner. Obesity-focused Metsera unveils leadership team.
Max Bayer
,
Gabrielle Masson
Apr 19, 2024 8:30am
Nvidia grows drug research footprint with Amgen, Recursion pacts
Jan 8, 2024 1:00pm
Recursion lines up $50M Nvidia collab for AI drug discovery
Jul 12, 2023 12:32pm
Gilead taps Roche exec to fly Kite—Chutes & Ladders
May 19, 2023 9:30am
Recursion dumps rare disease asset while raking in $150M
Oct 26, 2022 11:00am
BIO'22 marked by first-time handshakes and attempts at survival
Jun 15, 2022 7:25am